- Home
- TPST vs DLXY Comparison
TPST vs DLXY Comparison
Compare TPST & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TPST | DLXY |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1M | 14.7M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | TPST | DLXY |
|---|---|---|
| Price | $2.47 | $0.94 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 90.3K | 60.4K |
| Earning Date | 03-26-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1077.13 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $273,155,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.35 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.17 | $0.61 |
| 52 Week High | $12.48 | $7.16 |
Technical Indicators
Market Signals| Indicator | TPST | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 28.70 | 46.94 |
| Support Level | $2.55 | $0.82 |
| Resistance Level | $3.00 | $1.12 |
| Average True Range (ATR) | 0.23 | 0.14 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 3.06 | 18.91 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.